A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Patients with Moderate to Severe Allergic Asthma
HEALTHY PARTICIPANTS: No
The purpose of this study is to compare the effects, good or bad, of omalizumab versus placebo on your ability to do physical activity and improve sleep for patients with allergic asthma. In this study, you will receive either omalizumab or placebo. A placebo looks like a drug but has no active ingredient.
Who Can Participate
Participants who are between 18 and 65 years old, have been diagnosed with allergic asthma for one or more years, and have difficulty doing exercise or wake up from sleep due to asthma may be eligible for the study.